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Case Report
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Summary  Fibromuscular  dysplasia  (FMD)  is  one  of  the  etiologies  of  renal  artery
stenosis (RAS)  and  secondary  hypertension.  Balloon  angioplasty  has  emerged  as  the
mainstay of  treatment  because  patients  with  FMD  usually  show  substantial  clin-
ical and  anatomic  response  to  renal  angioplasty  without  stenting.  We  report  a
21-year-old  male  case  of  FMD-induced  RAS  treated  with  intravascular  ultrasound-
and pressure  gradient-guided  renal  angioplasty.  Ultrasonic  imaging  of  the  stenotic
renal artery  clearly  visualized  adventitial  ﬁbrotic  band  surrounding  the  negativeRenovascular
hypertension;
Vascular
interventions
remodeled renal  artery  and  the  accompanying  atherosclerotic  plaque.  The  ﬁndings  sug-
gest that  atherosclerotic  change  can  occur  in  young  patients  with  renal  FMD  that  is  basically
considered to  be  nonatherosclerotic.  Pressure  gradient  measurement  is  also  useful  in  conﬁrming
hemodynamic  improvement  during  angioplasty.
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ibromuscular  dysplasia  (FMD)  is  one  of  the  causes  of
enal  artery  stenosis  (RAS),  and  is  generally  considered  a
onatherosclerotic  vascular  disease.  Although  FMD  RAS  is
haracterized  by  angiographic  ‘‘string  of  beads’’  appear-
nce,  the  typical  angiographic  morphology  is  absent  in
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Figure  1  Baseline-  and  captopril-renoscintigraphy  with  Tc-99m  diethylene  triamine  penta-acetic  acid  (DTPA).  (A)  Before  percu-
taneous transluminal  renal  angioplasty  (PTRA),  baseline-99mTc-DTPA  renoscintigraphy  demonstrated  a  decrease  in  the  left  kidney’s
glomerular ﬁltration  rate  (GFR,  22.2  ml/min).  Captopril-99mTc-DTPA  renoscintigraphy  showed  that  GFR  of  the  left  kidney  was  low-
ered than  that  of  the  control  [captopril-induced  reduction  rate  (CRR,  17.4%),  which  was  calculated  from  the  renal  uptake  before
(22.2 ml/min)  and  after  (18.4  ml/min)  captopril],  while  GFR  of  the  right  kidney  increased  by  captopril  loading.  (B)  Post-PTRA
renoscintigraphy  showed  the  improvement  on  the  left  kidney’s  GFR  and  CRR  (2.2%  from  17.4%  at  pre-PTRA).
Figure  2  Noninvasive  morphological  evaluation  of  renal  artery  stenosis.  (A)  A  computed  tomography  (CT)  angiography  visualized
tandem lesion  at  middle  segment  of  the  left  renal  artery.  Note  the  location  of  stenosis  and  absence  of  atherosclerotic  change  such  as
arterial wall  irregularity  and  calciﬁcation.  (B)  A  magnetic  resonance  (MR)  angiography  demonstrated  the  severe  stenosis  at  middle
to distal  segment  of  left  renal  artery  as  well.  (C)  The  left  kidney  was  mildly  atrophic  compared  with  right  kidney.  MRI,  magnetic
resonance imaging.
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Figure  3  The  pre-  and  post-percutaneous  transluminal  renal  angioplasty  (PTRA)  selective  left  renal  arteriogram  (top  and  bot-
tom) and  serial  grayscale  intravascular  ultrasound  (IVUS)  and  IVUS-derived  tissue  component  of  ﬁbromuscular  dysplastic  region.
Consistent with  computed  tomography  and  magnetic  resonance  angiography,  pre-PTRA  selective  left  renal  arteriogram  (on  the
top) showed  tandem  lesion  at  middle  segment  of  left  renal  artery.  (A)  At  proximal  portion  of  the  stenotic  lesion,  gray-scale  IVUS
visualized severely  negative  remodeled  renal  artery  and  thick  ﬁbrotic  band  surrounding  the  stenosis.  The  region  was  ﬁbrotic  and
appeared to  involve  the  adventitia.  Note  the  absence  of  atherosclerotic  plaque  at  the  segment.  (A′)  The  cross-sectional  IVUS
panel corresponds  to  pre-PTRA  cross-sectional  IVUS  image  ‘‘A.’’  The  negative  remodeled  renal  artery  was  dramatically  expanded
by balloon  angioplasty  without  any  renal  artery  dissection.  Note  the  small  renal  vein  at  9—10  o’clock  on  the  pre-  and  post-PTRA
IVUS images  that  corresponds  to  the  same  small  renal  vein  on  the  IVUS  images.  (B)  At  distal  portion  of  the  stenotic  lesion,  gray-
scale IVUS  identiﬁed  decreased  lumen  areas  and  concentric  ﬁbrotic  band  surrounding  the  stenosis  as  well  as  the  proximal  portion.
Unlike the  proximal  segment,  here  eccentric  atherosclerotic  plaque  was  accompanied  with  ﬁbromuscular  dysplasia  at  1—6  o’clock.
Newly developed  IVUS-based  tissue  characterization  software  (iMapTM)  demonstrates  the  ability  to  characterize  coronary  plaque
tissue using  an  IVUS  +  radiofrequency  system.  Using  40  MHz  mechanical  IVUS  transducer,  iMapTM analysis  coded  tissue  as  light-green
(ﬁbrotic), yellow  (lipidic),  pink  (necrotic),  and  light-blue  (calciﬁed).  The  iMapTM tissue  characterization  software  recognized  both
the atherosclerotic  plaque  [left  panel  of  (B)]  and  the  segmental  adventitial  layer  [right  panel  of  (B)]  as  ‘‘ﬁbrotic.’’  It  is  also  worth
noting that  the  ﬁbromuscular  dysplasia-associated  atherosclerotic  plaque  was  not  highly  atherosclerotic,  such  as  calciﬁed  and
necrotic plaque.  (B′)  The  cross-sectional  IVUS  panel  corresponds  to  pre-PTRA  cross-sectional  IVUS  image  ‘‘B.’’  The  ﬁbromuscular
dysplastic region  was  successfully  dilated  by  balloon  angioplasty  without  any  dissection.  Note  the  small  renal  vein  at  10—11  o’clock
on the  pre-  and  post-PTRA  IVUS  images  that  corresponds  to  the  same  small  renal  vein  on  the  IVUS  images.  (For  interpretation  of  the
references to  color  in  this  ﬁgure  legend,  the  reader  is  referred  to  the  web  version  of  the  article.)
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Figure  4  Pre-  and  post-percutaneous  transluminal  renal  angioplasty  (PTRA)  PressureWire  measurement  depicting  the  phasic  and
mean proximal  renal  artery  pressure,  phasic  and  mean  distal  renal  artery  pressure,  and  the  mean  distal  to  proximal  artery  pressure
ratio. (A)  Using  a  PressureWireTM Certus  (St.  Jude  Medical,  St.  Paul,  MN,  USA),  the  distal  renal  artery  and  aortic  pressures  were
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aecorded with  a  pressure  gradient  of  70  mmHg.  (B)  After  successf
ystolic gradient  across  the  stenosis  decreased  to  approximatel
ome  cases.  Also,  the  optimal  endpoint  of  interventional
evascularization  for  RAS  has  not  been  clearly  established.
ere,  we  present  an  interesting  case  of  FMD  RAS  evaluated
y  multimodality  such  as  intravascular  ultrasound  (IVUS),
cintigraphy,  and  intravascular  pressure  gradient.
ase report
 21-year-old  man  with  drug-resistant  hypertension  was
dmitted  to  our  institute.  Both  baseline-  and  captopril-
enoscintigraphy  revealed  a  decrease  in  the  left  kidney’s
lomerular  ﬁltration  rate  (GFR)  and  captopril-induced  addi-
ional  GFR  reduction  (Fig.  1).  A  computed  tomography,
agnetic  resonance  angiography  and  renal  arteriogra-
hy  (Figs.  2  and  3)  demonstrated  left  RAS  that  seemed
o  be  accountable  for  activated  renin—aldosterone  sys-
em  [plasma  renin  activity  (PRA,  5.6  ng/ml/h)  and  plasma
ldosterone  concentration  (PAC,  233  pg/ml)];  thus,  he  was
cheduled  to  undergo  percutaneous  transluminal  renal
ngioplasty  (PTRA).  The  distal  renal  artery  and  aortic  pres-
ures  were  recorded  with  a  pressure  gradient  of  70  mmHg
Fig.  4).  IVUS  identiﬁed  decreased  lumen  areas  and  con-
entric  ﬁbrotic  band  surrounding  the  stenosis  (Fig.  3).  Also,
VUS  visualized  that  distal  part  of  the  stenosis  was  accom-
anied  with  eccentric  atherosclerotic  plaque.  IVUS-derived
MapTM tissue  characterization  software  (Boston  Scientiﬁc
a
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IRA,  the  distal  renal  artery  to  proximal  renal  artery  peak-to-peak
mmHg.
orp.,  Natick,  MA,  USA)  recognized  the  segmental  adven-
itial  layer  as  ‘‘ﬁbrotic’’  hyperplasia.  The  ﬁbrotic  lesion
ould  be  easily  dilated  by  3.0-  and  3.5-mm  balloons  with
ominal  dilatation  pressure.  Post-PTRA  IVUS  revealed  an
ncreased  lumen  area  and  vessel  expansion  without  any  dis-
ection.  The  peak-to-peak  systolic  pressure  gradient  across
he  stenosis  decreased  from  70  mmHg  to  10  mmHg.  Post-
TRA  renoscintigraphy  showed  an  improvement  in  the  GFR,
nd  his  activated  renin—aldosterone  system  was  promptly
ormalized  (PRA,  0.3  ng/ml/h;  PAC,  18.2  pg/ml).
iscussion
MD  is  generally  considered  a  nonatherosclerotic  vascular
isease  that  commonly  affects  the  renal  and  internal  carotid
rteries.  Renal  FMD  occurs  in  the  middle  or  distal  arte-
ial  segments  in  younger  patients  with  few  cardiovascular
isk  factors,  while  atherosclerotic  RAS  typically  occurs  at
he  ostium  and  proximal  portions  in  older  patients  with
ultiple  risks.  In  the  current  case,  FMD  was  easily  pre-
umed  as  a  primary  cause  of  RAS  from  the  anatomical
nd  clinical  features,  however,  typical  ‘‘string  of  beads’’
ppearance  was  not  observed  on  the  angiogram.  Unlike
ommon  medial  FMD,  adventitial  FMD  was  reported  to  be
ery  rare  and  may  have  a  focal  stenotic  appearance  [1].
VUS  imaging  of  the  stenotic  renal  artery  clearly  visualized
CI
f
l
A
T
r
S
R
[
[
[
[4] Gross CM, Kramer J, Weingartner O, Uhlich F, Luft FC, WaigandIVUS-  and  pressure  gradient-guided  renal  angioplasty  
adventitial  ﬁbrotic  band  surrounding  the  negative  remod-
eled  renal  artery  and  the  accompanying  atherosclerotic
plaque,  suggesting  that  atherosclerotic  change  can  occur  in
young  patients  with  renal  FMD  that  has  been  basically  con-
sidered  to  be  nonatherosclerotic.  Consistent  with  pathologic
study  which  showed  that  the  ﬁbroplastic  lesion  was  charac-
terized  by  a  dense  accumulation  of  elastic  tissue  [2],  the
dysplastic  region  was  homogeneously  ﬁbrotic  in  gray-scale
IVUS,  and  was  coded  as  uniformly  ﬁbrotic  tissue  in  iMapTM
software  as  well.
The  use  of  stents  for  FMD  has  been  reserved  as  a
‘‘bailout’’  procedure  in  cases  in  which  there  are  subopti-
mal  results  with  balloon  angioplasty  or  in  which  renal  artery
dissection  occurs,  because  patients  with  FMD  usually  show
substantial  clinical  and  anatomic  response  to  PTRA  with-
out  stenting  [3].  Especially  in  the  current  young  case,  renal
stenting,  that  necessitates  indeﬁnite  aspirin  intake,  should
be  avoided  as  much  as  possible.  In  atherosclerotic  RAS,  a  sys-
tolic  pressure  gradient  of  >20  mmHg  may  more  accurately
detect  a  clinically  signiﬁcant  stenosis  [4].  In  the  current
case,  the  pressure  gradient  reduction  from  70  mmHg  to
10  mmHg  was  associated  with  an  improvement  in  renal  blood
ﬂow  and  normalization  of  the  renin—aldosterone  system.
Taken  together,  the  combined  use  of  IVUS  and  intravas-
cular  pressure  gradient  provides  us  with  decision-making
safety  (absence  of  post-PTRA  renal  artery  perfora-
tion/dissection  by  IVUS)  and  efﬁcacy  (post-PTRA  lumen
enlargement  by  IVUS  and  hemodynamic  improvement  by
intravascular  pressure  gradient)  information  during  PTRA.e167
onclusion
n  conclusion,  such  multimodality  work-up  could  be  useful
or  etiological  evaluation  in  patients  with  RAS,  and  might
ead  to  optimal  strategy  in  PTRA  for  RAS.
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